Study of Welgenaleucel (UWC19) in Patients With Relapsed or Refractory B-cell Lymphoma

Clinical trial NCT04296461 · UNKNOWN

Trial details

NCT number: NCT04296461
Sponsor: UWELL Biopharma
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

B-cell Non-Hodgkin Lymphoma

Start date: 2020-07-27
Primary completion: 2021-06-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.